AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

sinus infection: 500 mg every 12 hours: 10 days: skin infection: 500 to 750 mg every 12 hours: 7 to 14 days: typhoid: 500 mg every 12 hours: 10 days: Cipro dosage for children.